Who owns ENANTA PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ENTA from SEC Form 13F filings across 121 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 121 institutions disclosed 27.0M shares of ENANTA PHARMACEUTICALS INC worth $393.5M — about 92.8% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
121
13F holders
$393.5M
value, 2026 filers
92.8%
of shares outstanding (27.0M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ENTA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 3.7M | $53.3M | 0.0% | 12.6% | new |
| 2 | BlackRock, Inc. | 3.2M | $47.3M | 0.0% | 11.2% | +4.5% |
| 3 | Krensavage Asset Management, LLC | 2.9M | $41.8M | 15.9% | 9.9% | 0.0% |
| 4 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.4M | $35.3M | 0.2% | 8.3% | -15.8% |
| 5 | Deep Track Capital, LP | 1.4M | $21.1M | 0.3% | 5% | -26.2% |
| 6 | ADAR1 Capital Management, LLC | 1.3M | $19.6M | 0.9% | 4.6% | +2518.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $17.7M | 0.0% | 4.2% | +2.9% |
| 8 | Spruce Street Capital LP | 1.1M | $15.9M | 3.1% | 3.7% | +16.7% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 1.1M | $15.7M | 0.0% | 3.7% | +22.5% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.0M | $14.7M | 0.0% | 3.5% | +6.6% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 776,634 | $11.3M | 0.0% | 2.7% | +7.1% |
| 12 | MILLENNIUM MANAGEMENT LLC | 643,967 | $9.4M | 0.0% | 2.2% | -27.0% |
| 13 | STATE STREET CORP | 576,117 | $8.4M | 0.0% | 2% | +2.5% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 557,600 | $8.1M | 0.0% | 1.9% | -16.2% |
| 15 | Hillsdale Investment Management Inc. | 468,000 | $6.8M | 0.2% | 1.6% | +7.5% |
| 16 | GOLDMAN SACHS GROUP INC | 464,649 | $6.8M | 0.0% | 1.6% | +75.3% |
| 17 | MORGAN STANLEY | 315,729 | $4.6M | 0.0% | 1.1% | +2.0% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 301,151 | $4.4M | 0.0% | 1% | +2.1% |
| 19 | DIMENSIONAL FUND ADVISORS LP | 282,682 | $4.1M | 0.0% | 1% | +39.1% |
| 20 | NORTHERN TRUST CORP | 259,696 | $3.8M | 0.0% | 0.9% | +7.8% |
| 21 | AQR CAPITAL MANAGEMENT LLC | 256,870 | $3.7M | 0.0% | 0.9% | -18.0% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 185,618 | $2.7M | 0.0% | 0.6% | +5.6% |
| 23 | Connor, Clark & Lunn Investment Management Ltd. | 153,008 | $2.2M | 0.0% | 0.5% | +21.7% |
| 24 | Rockefeller Capital Management L.P. | 150,546 | $2.2M | 0.0% | 0.5% | +5773.8% |
| 25 | MARSHALL WACE, LLP | 131,995 | $1.9M | 0.0% | 0.5% | -37.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.